Base de dados : MEDLINE
Pesquisa : E01.370.225.812.871.610 [Categoria DeCS]
Referências encontradas : 9605 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 961 ir para página                         

  1 / 9605 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29390311
[Au] Autor:Suwarsa O; Rahardjo RM; Sutedja E; Dharmadji HP; Hindritiani R; Gunawan H
[Ad] Endereço:Division of Allergy and Immunology, Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran-Dr. Hasan Sadikin Hospital, Bandung, Indonesia.
[Ti] Título:Systemic contact dermatitis due to corrosion of titanium-coated nickel and cobalt bone plate fixation: A case report.
[So] Source:Medicine (Baltimore);96(50):e9120, 2017 Dec.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:RATIONALE: Corrosion refers to the degradation of a material that occurs following its interaction with other substances in the environment. Corrosion of metallic substances into tissues may lead to inflammatory responses such as systemic contact dermatitis (SCD), a skin condition where an individual who has previously been sensitized to a particular allergen via the cutaneous route will subsequently react to same allergen via the systemic route. This condition occurs following exposure to allergens such as metals, medications, and certain food substances. In recent years, the use of metal plates for internal fixation has become increasingly common in bone fracture repairs. PATIENT CONCERNS: A 34-year-old Indonesian male presented with systemic erythema with itching 7 days following a bone plate fixation as a management for mandibular fracture. DIAGNOSES: Physical examination showed pruritic red macules, papules, and scales on almost his entire body, along with facial swelling. The patch test results revealed a positive reaction to nickel and cobalt. Therefore, the patient was diagnosed with SCD. INTERVENTIONS: The patient was treated with topical and systemic corticosteroids as well as bone plate removal. OUTCOME: After treatment, the eruption turned brown, the itching was resolved, and there were no facial swelling as well. LESSONS: This case report highlights the need to consider the occurrence of SCD in patients following bone plate fixation.
[Mh] Termos MeSH primário: Placas Ósseas
Dermatite de Contato/etiologia
Dermatite de Contato/terapia
Fixação Interna de Fraturas/instrumentação
Fraturas Mandibulares/cirurgia
[Mh] Termos MeSH secundário: Corticosteroides/uso terapêutico
Adulto
Cobalto
Corrosão
Remoção de Dispositivo
Seres Humanos
Masculino
Níquel
Testes do Emplastro
Titânio
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Adrenal Cortex Hormones); 3G0H8C9362 (Cobalt); 7OV03QG267 (Nickel); D1JT611TNE (Titanium)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180301
[Lr] Data última revisão:
180301
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180203
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009120


  2 / 9605 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:29394016
[Au] Autor:Nualsri C; Lourith N; Kanlayavattanakul M
[Ti] Título:Development and clinical evaluation of green tea hair tonic for greasy scalp treatment.
[So] Source:J Cosmet Sci;67(3):161-66, 2016 May-Jun.
[Is] ISSN:1525-7886
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Green tea has cosmetic benefits that include activities against androgen disorders. A hair tonic containing green tea for reduction of scalp sebum was developed and clinically evaluated. Stable green tea hair tonics were closed-patch tested and clinically evaluated in 20 volunteers for 28 days by using a Sebumeter ® . Hair tonic base with glycerin and butylene glycol (total 4%) gained the highest consumers' preference was incorporated with green tea extract. All of the products were stable and none caused skin irritation. Green tea hair tonic (2%) significantly (p ≤ 0.024) lowered scalp sebum for 21 and 28 days following the application, suggesting that this topical therapy of scalp greasiness is safe and efficient.
[Mh] Termos MeSH primário: Preparações para Cabelo/uso terapêutico
Extratos Vegetais/uso terapêutico
Dermatoses do Couro Cabeludo/tratamento farmacológico
Sebo/efeitos dos fármacos
Chá
[Mh] Termos MeSH secundário: Administração Cutânea
Adulto
Feminino
Preparações para Cabelo/farmacologia
Seres Humanos
Masculino
Testes do Emplastro
Extratos Vegetais/farmacologia
Valores de Referência
Sebo/secreção
Adulto Jovem
[Pt] Tipo de publicação:CLINICAL TRIAL; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Hair Preparations); 0 (Plant Extracts); 0 (Tea)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180215
[Lr] Data última revisão:
180215
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:180203
[St] Status:MEDLINE


  3 / 9605 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:27775977
[Au] Autor:Grey KR; Hanson JL; Hagen SL; Hylwa SA; Warshaw EM
[Ad] Endereço:From the *University of Minnesota Medical School; †Parkside Occupational and Contact Dermatitis Clinic, Hennepin County Medical Center; ‡Department of Dermatology, Minneapolis Veterans Affairs Medical Center; and §Department of Dermatology, University of Minnesota Medical School, Minneapolis, MN.
[Ti] Título:Epidemiology and Co-Reactivity of Novel Surfactant Allergens: A Double-Blind Randomized Controlled Study.
[So] Source:Dermatitis;27(6):348-354, 2016 Nov/Dec.
[Is] ISSN:2162-5220
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Surfactants are cleansing agents used in products such as shampoos and soaps. OBJECTIVES: The aims of this study were to identify positivity rates to 3 novel amide-containing surfactants (sodium lauroyl sarcosinate, isostearamidopropyl morpholine lactate, and disodium lauroamphodiacetate) and evaluate co-reactivity with other surfactants in patients with known surfactant sensitivity. METHODS: Previously patch-tested, surfactant-positive patients were identified via chart review and invited to participate. Participants were patch tested to screening surfactants (cocamidopropyl betaine, amidoamine, dimethylaminopropylamine, cocamide diethanolamine [DEA], oleamidopropyl dimethylamine, and decyl glucoside), as well as 3 novel surfactants: sodium lauroyl sarcosinate 0.5% and 1.0% aq, isostearamidopropyl morpholine lactate 0.5% and 1.0% aq, disodium lauroamphodiacetate 1.0 and 2.0% aq, and a hypoallergenic liquid cleanser (tested semiopen). Participants and clinicians were blinded. The order of tested allergens was randomized. RESULTS: Forty-seven participants completed the study. Excluding doubtful reactions, positive reactions were most common to oleamidopropyl dimethylamine (34%) and dimethylaminopropylamine (34%), followed by isostearamidopropyl morpholine lactate (23%). Reactivity was not associated with history of childhood eczema. Co-reactivity was high among oleamidopropyl dimethylamine, dimethylaminopropylamine, cocamidopropyl betaine, amidoamine, and isostearamidopropyl morpholine lactate. None of the participants who reacted to cocamide DEA reacted to an additional surfactant. CONCLUSIONS: Isostearamidopropyl morpholine lactate may be an important emerging allergen with sensitivity rates comparable with those of oleamidopropyl dimethylamine and dimethylaminopropylamine. Co-reactivity among surfactants was frequent except for cocamide DEA.
[Mh] Termos MeSH primário: Alérgenos/efeitos adversos
Dermatite Alérgica de Contato/etiologia
Tensoativos/efeitos adversos
[Mh] Termos MeSH secundário: Adulto
Idoso
Idoso de 80 Anos ou mais
Dermatite Alérgica de Contato/diagnóstico
Dermatite Alérgica de Contato/epidemiologia
Método Duplo-Cego
Feminino
Seres Humanos
Masculino
Meia-Idade
Testes do Emplastro
Sarcosina/efeitos adversos
Sarcosina/análogos & derivados
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Nm] Nome de substância:
0 (Allergens); 0 (Surface-Active Agents); 632GS99618 (sarkosyl); Z711V88R5F (Sarcosine)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180212
[Lr] Data última revisão:
180212
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161025
[St] Status:MEDLINE


  4 / 9605 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:27775972
[Au] Autor:Zahir A; Kindred C; Blömeke B; Goebel C; Gaspari AA
[Ad] Endereço:From the *Department of Dermatology, School of Medicine, University of Maryland Baltimore; †Union Memorial Hospital, Baltimore, MD; ‡Department of Environmental Toxicology, University of Trier; and §The Procter & Gamble Company, Central Product Safety, Schwalbach am Taunus, Germany.
[Ti] Título:Tolerance to a Hair Dye Product Containing 2-Methoxymethyl-P-Phenylenediamine in an Ethnically Diverse Population of P-Phenylenediamine-Allergic Individuals.
[So] Source:Dermatitis;27(6):355-361, 2016 Nov/Dec.
[Is] ISSN:2162-5220
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Allergic contact dermatitis after exposure to p-phenylenediamine (PPD)-containing hair dye products is a common and important clinical problem. Because there is a high rate of cross-elicitation of allergic contact dermatitis to other important hair dye products (such as p-toluene diamine and other aminophenol hair dyes) in PPD-allergic patients, safer alternative dyes with excellent hair coloring options are needed. OBJECTIVE: This study aimed to study tolerance to Me-PPD in a PPD-allergic cohort. METHODS: Twenty ethnically diverse volunteers with a history of contact dermatitis to hair dyes or other PPD-containing chemicals and positive patch test results to 1% PPD in petrolatum were recruited to study their immediate and delayed skin reactivity to PPD, vehicle control, and 2-methoxy-methyl-PPD (Me-PPD) using the allergy alert test (simulating hair dyeing conditions) on volar forearm skin. This test is a short-contact open patch test. CONCLUSIONS: The Me-PPD may offer a safer alternative for PPD-allergic patients with an absent or reduced elicitation response in the allergy alert test simulating hair dye use conditions. The absent or reduced response to Me-PPD diagnosed using the allergy alert test has been shown to help reduce the possibility of moderate to severe cross-elicitation reactions among consumers during hair dyeing.
[Mh] Termos MeSH primário: Dermatite Alérgica de Contato/etiologia
Grupos Étnicos
Tinturas para Cabelo/efeitos adversos
Fenilenodiaminas/efeitos adversos
[Mh] Termos MeSH secundário: Adulto
Afroamericanos
Idoso
Grupo com Ancestrais do Continente Asiático
Estudos de Coortes
Reações Cruzadas/imunologia
Dermatite Alérgica de Contato/epidemiologia
Dermatite Alérgica de Contato/etnologia
Dermatite Alérgica de Contato/imunologia
Grupo com Ancestrais do Continente Europeu
Feminino
Seres Humanos
Masculino
Meia-Idade
Testes do Emplastro
Fenilenodiaminas/imunologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (2-methoxymethyl-p-phenylenediamine); 0 (Hair Dyes); 0 (Phenylenediamines); U770QIT64J (4-phenylenediamine)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180212
[Lr] Data última revisão:
180212
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161025
[St] Status:MEDLINE


  5 / 9605 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:27778425
[Au] Autor:Admani S; Goldenberg A; Jacob SE
[Ad] Endereço:Department of Dermatology, University of California, San Diego, La Jolla, California.
[Ti] Título:Contact Alopecia: Improvement of Alopecia with Discontinuation of Fluocinolone Oil in Individuals Allergic to Balsam Fragrance.
[So] Source:Pediatr Dermatol;34(1):e57-e60, 2017 Jan.
[Is] ISSN:1525-1470
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Inflammatory scalp dermatoses can be associated with alopecia, which is nonscarring and reversible in its early stages. This association has been described in seborrheic dermatitis, psoriasis, and atopic dermatitis. We describe three girls with alopecia aggravated by contact allergy to balsam fragrances. All three had complete resolution with avoidance of balsam of Peru and other balsam derivatives (including discontinuation of fluocinolone oil, which contains balsam of pine).
[Mh] Termos MeSH primário: Alérgenos/efeitos adversos
Alopecia/induzido quimicamente
Bálsamos/efeitos adversos
Dermatite Alérgica de Contato/etiologia
Perfumes/efeitos adversos
[Mh] Termos MeSH secundário: Adolescente
Alopecia/diagnóstico
Pré-Escolar
Dermatite Alérgica de Contato/diagnóstico
Feminino
Seres Humanos
Testes do Emplastro
[Pt] Tipo de publicação:CASE REPORTS
[Nm] Nome de substância:
0 (Allergens); 0 (Balsams); 0 (Perfume); 8P5F881OCY (Peruvian balsam)
[Em] Mês de entrada:1704
[Cu] Atualização por classe:180207
[Lr] Data última revisão:
180207
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:161026
[St] Status:MEDLINE
[do] DOI:10.1111/pde.13011


  6 / 9605 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28917483
[Au] Autor:Hsu CY; Lee WR; Shih YH
[Ad] Endereço:Department of Dermatology, Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan.
[Ti] Título:Recalcitrant chronic leg ulcer: An indication for patch testing for hydrocolloid dressing.
[So] Source:J Am Acad Dermatol;77(4):e97-e98, 2017 10.
[Is] ISSN:1097-6787
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Curativos Hidrocoloides/efeitos adversos
Dermatite Alérgica de Contato/etiologia
Úlcera da Perna/terapia
Testes do Emplastro
Cicatrização/fisiologia
[Mh] Termos MeSH secundário: Doença Crônica
Dermatite Alérgica de Contato/imunologia
Progressão da Doença
Seguimentos
Seres Humanos
Úlcera da Perna/diagnóstico
Úlcera da Perna/imunologia
Medição de Risco
Suspensão de Tratamento
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171018
[Lr] Data última revisão:
171018
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170918
[St] Status:MEDLINE


  7 / 9605 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28512370
[Au] Autor:Herrera-Mozo I; Sanz-Gallen P; Martí-Amengual G
[Ad] Endereço:Clinica Creu Blanca, Barcelona, Spain (Unit of Allergy). herreramozo.i@gmail.com.
[Ti] Título:Occupational contact allergy to omeprazole and ranitidine.
[Ti] Título:Occupational contact allergy to omeprazole and ranitidine..
[So] Source:Med Pr;68(3):433-435, 2017 May 16.
[Is] ISSN:0465-5893
[Cp] País de publicação:Poland
[La] Idioma:eng
[Ab] Resumo:Omeprazole is a proton pump inhibition and ranitidine is an H2 histamine receptor antagonist widely used in the treatment of gastroesophageal reflex disease, peptic ulcer disease, Zollinger-Ellison syndrome and as a protector of the gastric mucosae. We report a case of occupational contact allergy to omeprazole and ranitidine. A 48-year-old man, with no pre-existing history of atopy or lifestyle factors. He neither had any medical history of consumption of drugs such as ranitidine and omeprazole. He worked for 19 months in the pharmaceutical company that manufactured ranitidine base. He presented rash in the face and eczema on the dorsum of the hands with itching. The study by prick tests with ranitidine gave negative response. Patch testing with ranitidine base and ranitidine hydrochloride gave positive response. A month later, when the patient was asymptomatic he returned to the pharmaceutical company, being switched from this previous job to the reactor manufacturing omeprazole. A few days after that, he presented erythematous eruptions involving face and neck with itching. Prick tests, path tests and in vitro laboratories studies with omeprazole gave positives. In this case the patient presented hypersensitivity type I at omeprazole and hypersensitivity type IV at omeprazole and ranitidine. Our aportation indicates the importance of careful analysis of the occupational exposure histories of patients with the suspected type I or type IV hypersensitivity to allergens, to determine whether work exposure is the cause. Med Pr 2017;68(3):433-435.
[Mh] Termos MeSH primário: Dermatite Ocupacional/diagnóstico por imagem
Antagonistas dos Receptores Histamínicos H2/efeitos adversos
Omeprazol/efeitos adversos
Inibidores da Bomba de Prótons/efeitos adversos
Ranitidina/efeitos adversos
[Mh] Termos MeSH secundário: Eczema/induzido quimicamente
Exantema/induzido quimicamente
Seres Humanos
Masculino
Meia-Idade
Testes do Emplastro
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Histamine H2 Antagonists); 0 (Proton Pump Inhibitors); 884KT10YB7 (Ranitidine); KG60484QX9 (Omeprazole)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170922
[Lr] Data última revisão:
170922
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170518
[St] Status:MEDLINE


  8 / 9605 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28418125
[Au] Autor:White IR
[Ad] Endereço:Department of Dermatology, St John's Institute of Dermatology, London, SE1 9RT, U.K.
[Ti] Título:Quantitative risk assessment and the burden of fragrance contact allergy.
[So] Source:Br J Dermatol;176(4):860-861, 2017 04.
[Is] ISSN:1365-2133
[Cp] País de publicação:England
[La] Idioma:eng
[Mh] Termos MeSH primário: Dermatite Alérgica de Contato
Perfumes
[Mh] Termos MeSH secundário: Alérgenos
Seres Humanos
Testes do Emplastro
Medição de Risco
[Pt] Tipo de publicação:JOURNAL ARTICLE; COMMENT
[Nm] Nome de substância:
0 (Allergens); 0 (Perfume)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171107
[Lr] Data última revisão:
171107
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170419
[St] Status:MEDLINE
[do] DOI:10.1111/bjd.15399


  9 / 9605 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28411766
[Au] Autor:Ramirez F; Chren MM; Botto N
[Ad] Endereço:Department of Dermatology, University of California, San Francisco, San Francisco, California. Electronic address: faustine.ramirez@ucsf.edu.
[Ti] Título:A review of the impact of patch testing on quality of life in allergic contact dermatitis.
[So] Source:J Am Acad Dermatol;76(5):1000-1004, 2017 05.
[Is] ISSN:1097-6787
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Dermatite Alérgica de Contato/diagnóstico
Testes do Emplastro
Qualidade de Vida
[Mh] Termos MeSH secundário: Seres Humanos
[Pt] Tipo de publicação:LETTER; REVIEW
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171002
[Lr] Data última revisão:
171002
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170417
[St] Status:MEDLINE


  10 / 9605 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28398205
[Au] Autor:Oda T; Sawada Y; Yamaguchi T; Ohmori S; Haruyama S; Yoshioka M; Okada E; Nakamura M
[Ad] Endereço:Department of Dermatology, University of Occupational and Environmental Health, Kitakyushu, Japan.
[Ti] Título:Drug Eruption Caused by Rosuvastatin.
[So] Source:J Investig Allergol Clin Immunol;27(2):140-141, 2017.
[Is] ISSN:1018-9068
[Cp] País de publicação:Spain
[La] Idioma:eng
[Mh] Termos MeSH primário: Erupção por Droga/etiologia
Inibidores de Hidroximetilglutaril-CoA Redutases/efeitos adversos
Rosuvastatina Cálcica/efeitos adversos
[Mh] Termos MeSH secundário: Idoso
Betametasona/administração & dosagem
Betametasona/análogos & derivados
Biópsia
Erupção por Droga/diagnóstico
Erupção por Droga/tratamento farmacológico
Erupção por Droga/imunologia
Feminino
Glucocorticoides/administração & dosagem
Seres Humanos
Testes do Emplastro
Valor Preditivo dos Testes
Fatores de Risco
Resultado do Tratamento
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Glucocorticoids); 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors); 0 (betamethasone butyrate propionate); 83MVU38M7Q (Rosuvastatin Calcium); 9842X06Q6M (Betamethasone)
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170613
[Lr] Data última revisão:
170613
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170412
[St] Status:MEDLINE
[do] DOI:10.18176/jiaci.0136



página 1 de 961 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde